115 related articles for article (PubMed ID: 6189544)
1. Haemoglobin-F levels in urogenital cancers.
Müderrisoğlu C; Kansu E; Akdas A; Laleli Y; Firat D
Br J Urol; 1983 Jun; 55(3):264-7. PubMed ID: 6189544
[TBL] [Abstract][Full Text] [Related]
2. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
[No Abstract] [Full Text] [Related]
3. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
4. Fetal proteins in various tumors.
Alsabti EA; Safo M
Jpn J Exp Med; 1978 Aug; 48(4):283-5. PubMed ID: 81898
[TBL] [Abstract][Full Text] [Related]
5. [Tumor marker in urology].
Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
7. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
8. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
9. Testis tumor markers: how accurate are they?
deVere White R; Karian S; Hong WK; Olsson CA
J Urol; 1981 May; 125(5):661-3. PubMed ID: 6164799
[No Abstract] [Full Text] [Related]
10. Tumour markers in testicular tumours.
Chisholm GD
Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
[No Abstract] [Full Text] [Related]
11. Serum and cellular biologic tumor markers in patients with urologic cancer.
Javadpour N
Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
[TBL] [Abstract][Full Text] [Related]
12. [Lectin binding in immunohistologically AFP/HCG positive and negative testicular carcinoma].
Henke H; Balducci M; Dunzendorfer U
Urol Int; 1987; 42(1):53-7. PubMed ID: 2438837
[TBL] [Abstract][Full Text] [Related]
13. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
14. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
Wolf DJ; Williams JJ
Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
[No Abstract] [Full Text] [Related]
15. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic acid phosphatase, beta-choriogonadotropin and alpha fetoprotein in the serum of patients with breast cancer].
Góźdź S; Zagała A; Bukowski J; Słuszniak J; Korejba W; Kowalski D; Kowalska K; Banasińska E; Urbaniak A
Pol Tyg Lek; 1986 Sep; 41(35):1099-102. PubMed ID: 2432589
[No Abstract] [Full Text] [Related]
17. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
19. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
20. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
Lo RK; Johnson DE
J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
